Although the exact cellular sources and targets of IL-37 have not been identified in BLCA TME, we attempted to explore whether genetic and/or expression alterations of IL-37 and SIGIRR affect the involvement of various cell types infiltrating the tumor. The gene discussed is IL37; the disease is bladder transitional cell carcinoma.